David Hung, Director at NovoCure Ltd (NVCR), sold 2,945 shares at $15.77 ($46K) on 2026-06-02, disclosed to the SEC on 2026-06-03.
Seasonal sale ($46k) by Director — this insider has traded NVCR in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NUVB | BUY | 2025-04-08 | $1.3M | — | Filing → |
| AXON | BUY | 2017-04-19 | $20.0M | — | Filing → |
| MDVN | SELL | 2016-03-07 | $418K | — | Filing → |